InvestorsHub Logo
Followers 23
Posts 2036
Boards Moderated 0
Alias Born 12/06/2017

Re: None

Tuesday, 09/07/2021 12:27:09 PM

Tuesday, September 07, 2021 12:27:09 PM

Post# of 144817
This is very good news for the FDA and what they want :- PharmaCyte (PMCB) said Tuesday it completed an 18-month period of ongoing stability testing for its clinical trial product CypCaps as mandated by the US Food and Drug Administration.
"CypCaps remains stable and active at 18 months after completing the 18-month timepoint of ongoing product stability testing required," the biotechnology company said in a statement.
This means that the product has a minimum shelf life of 18 months when stored at minus 80 degrees Celsius, PharmaCyte said, adding that the next timepoint in the testing phase will be after two years of storage at the same temperature.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News